Documents

April 2012

• Energy And Commerce Proposes Repealing ACA Funds, Medmal Reform, Medicaid Cuts For Reconciliation
• FAH Comments On Duals Demonstration Guidance
• FDA Issues Nanotechnology Guidance On Cosmetics And Food
• Consumers' Groups File Amicus Brief In Suit Opposing Esi-Medco Merger
• Cosmetic Industry Backs Bill Giving FDA More Oversight Of Cosmetics
• CMS Notice Lays Out Hospital Inpatient Pay, Wage Index Policies
• Public Citizen Praises Leahy Bill Letting Generic Drug Makers Add Warnings To Labels
• Toomey's Budget Proposal Axes ACA, Block Grants Medicare, Includes Ryan Medicare Reforms
• House GOP Memo Outlining Budget Sequestration Process
• FDA Critical Path Initiative Announces New Head
• Draft Of Hatch's Long-Awaited Drug Shortage Bill
• Senate Health Committee Unveils Updated Draft Bipartisan User Fee Bill
• Surgeon General Looks For Ways To Get The Chronically Ill To Take Their Medicine
• GOP Senate Joint Economic Committee Report Says Reform Laws Raises Taxes
• CMS Announces Next Steps For Round 1 Of DMEPOS Competitive Bidding Program
• Burr, Coburn Bill Aims To Speed Drug Approvals By Hiking FDA Transparency, Accountability
• GPhA Applauds Supreme Court Drug Patent Decision
• Ways & Means Proposes Subsidy Recapture For Budget Reconciliation
• Senate Finance To Hold Hearing On Health Law Fraud Enforcement Tools
• House Energy & Commerce Panel Unveils Updated User Fee Discussion Draft
• Chamber's Exchange Comments
• Stakeholders Comment On FDA Biosimilars Guidances
• Comments On Overpayment Proposed Rule
• HHS Releases New Open Government Plan
• GOP Sens Press AHRQ ACA's MedMal Grants